99 related articles for article (PubMed ID: 8954046)
1. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics.
La Rosa GL; Ippolito AM; Lupo L; Cercabene G; Santonocito MG; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4385-7. PubMed ID: 8954046
[TBL] [Abstract][Full Text] [Related]
2. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment.
Vermiglio F; Lo Presti VP; Violi MA; Moleti M; Castagna MG; Finocchiaro MD; Mattina F; Mandolfino M; Zimbaro G; Trimarchi F
Clin Endocrinol (Oxf); 2003 Sep; 59(3):347-53. PubMed ID: 12919158
[TBL] [Abstract][Full Text] [Related]
3. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial.
Bennedbaek FN; Nielsen LK; Hegedüs L
J Clin Endocrinol Metab; 1998 Mar; 83(3):830-5. PubMed ID: 9506736
[TBL] [Abstract][Full Text] [Related]
4. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid.
La Rosa GL; Lupo L; Giuffrida D; Gullo D; Vigneri R; Belfiore A
Ann Intern Med; 1995 Jan; 122(1):1-8. PubMed ID: 7985890
[TBL] [Abstract][Full Text] [Related]
5. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses.
Zelmanovitz F; Genro S; Gross JL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3881-5. PubMed ID: 9814462
[TBL] [Abstract][Full Text] [Related]
6. The outcome of benign thyroid nodules correlates with the findings of fine needle biopsy.
Tseleni-Balafouta S; Katsouyanni K; Kitsopanides J; Koutras DA
Thyroidology; 1991 May; 3(2):75-8. PubMed ID: 1726904
[TBL] [Abstract][Full Text] [Related]
7. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.
Puzziello A; Carrano M; Angrisani E; Marotta V; Faggiano A; Zeppa P; Vitale M
J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459
[TBL] [Abstract][Full Text] [Related]
8. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.
Costante G; Crocetti U; Schifino E; Ludovico O; Capula C; Nicotera M; Arturi F; Filetti S
J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules.
Papini E; Bacci V; Panunzi C; Pacella CM; Fabbrini R; Bizzarri G; Petrucci L; Giammarco V; La Medica P; Masala M
Clin Endocrinol (Oxf); 1993 May; 38(5):507-13. PubMed ID: 8330445
[TBL] [Abstract][Full Text] [Related]
10. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V
J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852
[TBL] [Abstract][Full Text] [Related]
11. [Levothyroxine treatment of the solitary thyroid nodule].
Almodóvar Ruiz F; Maldonado Castro G; de Luis D; Lahera M; Varela da Costa C
An Med Interna; 2000 Feb; 17(2):99-101. PubMed ID: 10829467
[TBL] [Abstract][Full Text] [Related]
12. [Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results].
Wémeau JL; Cousty C; Vlaeminck V
Ann Endocrinol (Paris); 2000 May; 61(2):119-24. PubMed ID: 10891662
[TBL] [Abstract][Full Text] [Related]
13. [Benign thyroid nodules in the elderly. Medical treatment].
Cramarossa I; Caruso AA; Morena L; Salandri A
Minerva Endocrinol; 1998 Sep; 23(3):77-82. PubMed ID: 10063325
[TBL] [Abstract][Full Text] [Related]
14. [Hormonal suppressive therapy of thyroid nodules].
Latapie JL; Leprat F; N'Guyen D; Catargi B; Latapie MJ
Ann Endocrinol (Paris); 1997; 58(6):459-62. PubMed ID: 9686004
[TBL] [Abstract][Full Text] [Related]
15. The effect of thyroxine-suppressive therapy in patients with solitary non-toxic thyroid nodules -- a randomised, double-blind, placebo-controlled study.
Tsai CC; Pei D; Hung YJ; Wang TF; Tsai WC; Yao CY; Hsieh MC; Kuo SW
Int J Clin Pract; 2006 Jan; 60(1):23-6. PubMed ID: 16409424
[TBL] [Abstract][Full Text] [Related]
16. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.
Papini E; Petrucci L; Guglielmi R; Panunzi C; Rinaldi R; Bacci V; Crescenzi A; Nardi F; Fabbrini R; Pacella CM
J Clin Endocrinol Metab; 1998 Mar; 83(3):780-3. PubMed ID: 9506726
[TBL] [Abstract][Full Text] [Related]
17. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up.
Papini E; Guglielmi R; Bizzarri G; Graziano F; Bianchini A; Brufani C; Pacella S; Valle D; Pacella CM
Thyroid; 2007 Mar; 17(3):229-35. PubMed ID: 17381356
[TBL] [Abstract][Full Text] [Related]
18. [Current views on diagnostic standards and treatments with L-thyroxine of single non-toxic thyroid nodules or multinodular non-toxic goiter].
Lewiński A
Wiad Lek; 2001; 54 Suppl 1():21-30. PubMed ID: 12182027
[TBL] [Abstract][Full Text] [Related]
19. Thyroxine suppressive therapy in patients with nodular thyroid disease.
Gharib H; Mazzaferri EL
Ann Intern Med; 1998 Mar; 128(5):386-94. PubMed ID: 9490600
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation the effects of percutaneous ethanol injection on the volume of benign solitary solid cold thyroid nodules].
Meskhi I; Sikharulidze E
Georgian Med News; 2007 Nov; (152):7-10. PubMed ID: 18175824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
